Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Following the pandemic onset, a dramatic decrease in the number of cancer screening tests and ensuing diagnoses was observed (Bakouny et al., 2021; Chen et al., 2021; Patt et al., 2020). The consequent delays in diagnosis are expected to result in adverse oncologic outcomes (Hartman et al., 2020; Maringe et al., 2020). It is unknown to what extent screening pathways adapted during the pandemic, enabling the recovery of missed diagnoses.
Cancer Cell , commentaire en libre accès, 2020